To understand the role of IL-36R signaling in normal and diabetic corneal wound healing, we treated IL-36R-deficient mice (IL-36−/−) with streptozotocin to induce diabetes by administering multiple low doses of STZ (40 mg/kg, intraperitoneally) to mice on 5 consecutive days. Here, IL1RL2 is linked to diabetes mellitus.